Association Between Endothelial Biomarkers and Lipid and Glycemic Levels: A Cross-Sectional Study with Diabetic Patients

References

• International Diabetes Federation . IDF diabetes atlas (2021). https://diabetesatlas.org/atlas/tenth-edition
   Google Scholar
• World Health Organization . World health statistics 2020: monitoring health for the SDGs, sustainable development goals (2020). https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• Rajaobelina K , Dow C , Romana Mancini F et al. Population attributable fractions of the main type 2 diabetes mellitus risk factors in women: findings from the French E3N cohort. J. Diabetes 11(3), 242–253 (2019).
   PubMed Web of Science ®Google Scholar
• Li Y , Liu Y , Liu S et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Sig. Transduct. Target Ther. 8(1), 152 (2023).
   PubMed Web of Science ®Google Scholar
• Dal Canto E , Ceriello A , Rydén L et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur. J. Prev. Cardiol. 26(Suppl. 2), 25–32 (2019).
   PubMed Web of Science ®Google Scholar
• Khunti K , Ceriello A , Coss X , De Block C . Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res. Clin. Pract. 137, 137–148 (2018).
   PubMed Web of Science ®Google Scholar
• Leonova EI , Galzitskaya OV . Role of syndecans in lipid metabolism and human diseases. In: Lipids in Protein Misfolding. Gursky O ( Eds.), Springer, Boston, 241–258 (2015).
   Google Scholar
• Cahill PA , Redmond EM . Vascular endothelium e Gatekeeper of vessel health. Atherosclerosis 248, 97–109 (2016).
   PubMed Web of Science ®Google Scholar
• Ruszkowska-Ciastek B , Sokup A , Wernik T et al. Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2. J. Zhejiang Univ. Sci. B 16(5), 355–361 (2015).
   PubMed Web of Science ®Google Scholar
• Wang JB , Guan J , Shen J et al. Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 86(2), 83–88 (2009).
   PubMed Web of Science ®Google Scholar
• Hanks LJ , Casazza K , Judd SE et al. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults. PLOS ONE 10(3), e0122885 (2015).
   PubMed Web of Science ®Google Scholar
• He X , Hu X , Ma X et al. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 16(1), 77 (2017).
   PubMedGoogle Scholar
• Egli P , Aeschbacher S , Bossard M et al. Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general population. Clin. Chim. Acta. 478, 13–17 (2018).
   PubMed Web of Science ®Google Scholar
• Tonkonogi A , Carlsson AC , Helmersson-Karlqvist J et al. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Ups. J. Med. Sci. 121(3), 174–178 (2016).
   PubMed Web of Science ®Google Scholar
• Karmakova TA , Sergeeva NS , Kanukoev KY et al. Kidney injury molecule 1 (KIM-1): a multifunctional glycoprotein and biological marker (Review). Sovrem. Tekhnologii Med. 13(3), 64–78 (2021).
   PubMed Web of Science ®Google Scholar
• Peters R , Ee N , Peters J et al. Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction. Ther. Adv. Chronic Dis. 10, 2040622319880392 (2019).
   Web of Science ®Google Scholar
• American Diabetes Association . Classification and diagnosis of diabetes. Diabetes Care 39(Suppl. 1), S13–S22 (2016).
   PubMed Web of Science ®Google Scholar
• D’Agostino RB Sr , Pencina MJ , Massaro JM , Coady S . Cardiovascular disease risk assessment: insights from Framingham. Glob. Heart. 8(1), 11–23 (2013).
   PubMedGoogle Scholar
• American Diabetes Association . Cardiovascular disease and risk management. Diabetes Care 39(Suppl. 1), S60–S71 (2016).
   PubMedGoogle Scholar
• National High Blood Pressure Education Program . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute (US), MD, USA (2004). www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdf
   Google Scholar
• Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial (BR) . Recomendações da Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial (SBPC/ML): coleta e preparo da amostra biológica. Minha Editora, Barueri, Brazil (2014). www.sbpc.org.br/upload/conteudo/livro_coleta_biologica2013.pdf
   Google Scholar
• Friedewald WT , Levy RI , Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499–502 (1972).
   PubMed Web of Science ®Google Scholar
• Framingham Heart Study . Cardiovascular disease (10-year risk) (2017). https://framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/
   Google Scholar
• American Diabetes Association . Standards of medical care in diabetes – 2016 abridged for primary care providers. Clin. Diabetes 34(1), 3–21 (2016).
   PubMedGoogle Scholar
• Bertoluci MC , Moreira RO , Faludi A et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetol. Metab. Syndr. 9, 53 (2017).
   PubMed Web of Science ®Google Scholar
• Gabbay RA , Kendall D , Beebe C et al. Addressing therapeutic inertia in 2020 and beyond: a 3-year initiative of the American Diabetes Association. Clin. Diabetes 38(4), 371–381 (2020).
   PubMedGoogle Scholar
• Rattelman CR , Ciemins EL , Stempniewicz N et al. A retrospective analysis of therapeutic inertia in type 2 diabetes management across a diverse population of health care organizations in the USA. Diabetes Ther. 12(2), 581–594 (2021).
   PubMed Web of Science ®Google Scholar
• Papanas N , Elisaf M , Kotsa K et al. Adherence to the national guidelines for follow-up protocol in subjects with type 2 diabetes mellitus in Greece: The GLANCE Study. Diabetes Ther. 11(12), 2887–2908 (2020).
   PubMed Web of Science ®Google Scholar
• Palella E , Cimino R , Pullano AS et al. Laboratory parameters of hemostasis, adhesion molecules, and inflammation in type 2 diabetes mellitus: correlation with glycemic control. Int. J. Environ. Res. Public Health 17(1), 300 (2020).
   PubMed Web of Science ®Google Scholar
• Tryggestad JB , Shah RD , Braffett BH et al. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the treatment options for type 2 diabetes in adolescent and youth study. Pediatr. Diabetes 21(6), 923–931 (2020).
   PubMed Web of Science ®Google Scholar
• Néri AKM , Silva GBS Jr , Meneses GC et al. Cardiovascular risk assessment and association with novel biomarkers in patients with type 2 diabetes mellitus. Biomark. Med. 15(8), 561–576 (2021).
   PubMed Web of Science ®Google Scholar
• De Marañón AM , Iannantuoni F et al. Association between proinflammatory markers, leukocyte-endothelium interactions, and carotid intima-media thickness in type 2 diabetes: role of glycemic control. J. Clin. Med. 9(8), 2522 (2020).
   PubMed Web of Science ®Google Scholar
• Janowska J , Chudek J , Olszanecka-Glinianowicz M et al. Interdependencies among selected pro-inflammatory markers of endothelial dysfunction, C-peptide, anti-inflammatory interleukin-10 and glucose metabolism disturbance in obese women. Int. J. Med. Sci. 13(7), 490–499 (2016).
   PubMed Web of Science ®Google Scholar
• Izaguirre M , Gil MJ , Monreal I et al. The role and potential therapeutic implications of the fibroblast growth factors in energy balance and type 2 diabetes. Curr. Diab. Rep. 17(6), 43 (2017).
   PubMed Web of Science ®Google Scholar
• Ursem SR , Vervloet MG , Büttler RM et al. The interrelation between FGF23 and glucose metabolism in humans. J. Diabetes Complications 32(9), 845–850 (2018).
   PubMed Web of Science ®Google Scholar
• Reyes-Garcia R , Garcia-Martín A , García-Fontana B et al. FGF23 in type 2 diabetic patients: relationship with bone metabolism and vascular disease. Diabetes Care 37(5), e89–e90 (2014).
   PubMed Web of Science ®Google Scholar
• Bär L , Feger M , Fajol A et al. Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc. Natl. Acad. Sci. USA 115(22), 5804–5809 (2018).
   PubMed Web of Science ®Google Scholar
• Winther K , Nybo M , Vind B et al. Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients. Scand. J. Clin. Lab. Invest 72, 108–113 (2012).
   PubMed Web of Science ®Google Scholar
• Garland JS , Holden RM , Ross R et al. Insulin resistance is associated with fibroblast growth factor-23 in stage 3–5 chronic kidney disease patients. J. Diabetes Complications 28(1), 61–65 (2014).
   PubMed Web of Science ®Google Scholar
• Xu Y , Ma X , Pan X et al. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women. Cardiovasc. Diabetol. 17, 143 (2018).
   PubMed Web of Science ®Google Scholar
• Panwar B , Judd SE , Wadley VG et al. Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults. JAMA Cardiol. 3(4), 318–325 (2018).
   PubMed Web of Science ®Google Scholar
• Ashikaga E , Honda H , Suzuki H et al. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther. Apher. Dial. 14(3), 315–322 (2010).
   PubMed Web of Science ®Google Scholar
• Yeung SMH , Binnenmars SH , Gant CM et al. Fibroblast growth factor 23 and mortality in patients with type 2 diabetes and normal or mildly impaired kidney function. Diabetes Care 42(11), 2151–2153 (2019).
   PubMed Web of Science ®Google Scholar
• Song T , Fu Y , Wang Y et al. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI. BMC Cardiovasc. Disord. 21(1), 24 (2021).
   PubMed Web of Science ®Google Scholar
• Kutluturk Y , Akinci A , Ozerol IH , Yologlu S . The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents. J. Pediatr. Endocrinol. Metab. 32(7), 707–714 (2019).
   PubMed Web of Science ®Google Scholar
• Leonova EI , Galzitskaya OV . Role of syndecans in lipid metabolism and human diseases. Adv. Exp. Med. Biol. 855, 241–258 (2015).
   PubMed Web of Science ®Google Scholar
• Wang JB , Guan J , Shen J et al. Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 86(2), 83–88 (2009).
   PubMed Web of Science ®Google Scholar
• Wang JB , Zhang YJ , Zhang Y et al. Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol. 50(2), 111–115 (2013).
   PubMed Web of Science ®Google Scholar
• Nemoto T , Minami Y , Yamaoka-Tojo M et al. Endothelial glycocalyx and severity and vulnerability of coronary plaque in patients with coronary artery disease. Atherosclerosis 302, 1–7 (2020).
   PubMed Web of Science ®Google Scholar
• Emmens JE , Ter Maaten JM , Matsue Y et al. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. Eur. J. Heart Fail. 18(6), 641–649 (2016).
   PubMed Web of Science ®Google Scholar
• Figarska SM , Gustafsson S , Sundström J et al. Associations of circulating protein levels with lipid fractions in the general population. Arterioscler. Thromb. Vasc. Biol. 38(10), 2505–2518 (2018).
   PubMed Web of Science ®Google Scholar